| Year |
Citation |
Score |
| 2023 |
Li F, Ling X, Chakraborty S, Fountzilas C, Wang J, Jamroze A, Liu X, Kalinski P, Tang DG. Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence. Journal of Experimental & Clinical Cancer Research : Cr. 42: 213. PMID 37596619 DOI: 10.1186/s13046-023-02787-x |
0.369 |
|
| 2023 |
Pencik J, Philippe C, Schlederer M, Atas E, Pecoraro M, Grund-Gröschke S, Li WJ, Tracz A, Heidegger I, Lagger S, Trachtová K, Oberhuber M, Heitzer E, Aksoy O, Neubauer HA, ... ... Tang DG, et al. STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway. Molecular Cancer. 22: 133. PMID 37573301 DOI: 10.1186/s12943-023-01825-8 |
0.397 |
|
| 2023 |
Kirk JS, Wang J, Tracz A, Long M, Rosario SR, Ji Y, Kumar R, Liu X, Singh PK, Puzanov I, Chatta G, Cheng Q, Huang J, Wrana JL, Lovell J, ... ... Tang DG, et al. Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells. Biorxiv : the Preprint Server For Biology. PMID 36945493 DOI: 10.1101/2023.03.03.530998 |
0.511 |
|
| 2022 |
Li WJ, Liu X, Dougherty EM, Tang DG. MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development. Cancers. 14. PMID 36139695 DOI: 10.3390/cancers14184538 |
0.408 |
|
| 2022 |
Liu X, Li WJ, Puzanov I, Goodrich DW, Chatta G, Tang DG. Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness. Essays in Biochemistry. PMID 35866337 DOI: 10.1042/EBC20220003 |
0.435 |
|
| 2021 |
Cable J, Pei D, Reid LM, Wang XW, Bhatia S, Karras P, Melenhorst JJ, Grompe M, Lathia JD, Song E, Kuo CJ, Zhang N, White RM, Ma SK, Ma L, ... ... Tang DG, et al. Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. Annals of the New York Academy of Sciences. PMID 34850398 DOI: 10.1111/nyas.14719 |
0.433 |
|
| 2021 |
Tang DG. Understanding and targeting prostate cancer cell heterogeneity and plasticity. Seminars in Cancer Biology. PMID 34844845 DOI: 10.1016/j.semcancer.2021.11.001 |
0.599 |
|
| 2021 |
Tang DG, Kondo T. Cancer cell heterogeneity and plasticity: From molecular understanding to therapeutic targeting. Seminars in Cancer Biology. PMID 34626799 DOI: 10.1016/j.semcancer.2021.10.001 |
0.327 |
|
| 2021 |
Hu Q, Poulose N, Girmay S, Helevä A, Doultsinos D, Gondane A, Steele RE, Liu X, Loda M, Liu S, Tang D, Mills IG, Itkonen HM. Inhibition of CDK9 activity compromises global splicing in prostate cancer cells. Rna Biology. 1-8. PMID 34592899 DOI: 10.1080/15476286.2021.1983287 |
0.424 |
|
| 2021 |
Jamroze A, Chatta G, Tang DG. Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. Cancer Letters. PMID 34118355 DOI: 10.1016/j.canlet.2021.06.006 |
0.46 |
|
| 2021 |
Basu S, Dong Y, Kumar R, Jeter C, Tang DG. Slow-Cycling (Dormant) Cancer Cells in Therapy Resistance, Cancer Relapse and Metastasis. Seminars in Cancer Biology. PMID 33979674 DOI: 10.1016/j.semcancer.2021.04.021 |
0.491 |
|
| 2021 |
Li WJ, Wang Y, Liu R, Kasinski AL, Shen H, Slack FJ, Tang DG. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. Frontiers in Cell and Developmental Biology. 9: 640587. PMID 33763422 DOI: 10.3389/fcell.2021.640587 |
0.378 |
|
| 2021 |
Xu L, Yin Y, Li Y, Chen X, Chang Y, Zhang H, Liu J, Beasley J, McCaw P, Zhang H, Young S, Groth J, Wang Q, Locasale JW, Gao X, ... Tang DG, et al. A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33753479 DOI: 10.1073/pnas.2012748118 |
0.422 |
|
| 2021 |
Ji Y, Kumar R, Ghokale A, Chao HP, Rycaj K, Chen X, Li Q, Tang DG. LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor. Seminars in Cancer Biology. PMID 33476721 DOI: 10.1016/j.semcancer.2020.12.016 |
0.495 |
|
| 2020 |
Liu B, Kumar R, Chao HP, Mehmood R, Ji Y, Tracz A, Tang DG. Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer. Oncotarget. 11: 4243-4252. PMID 33245716 DOI: 10.18632/oncotarget.27818 |
0.441 |
|
| 2020 |
Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter C, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, ... ... Tang DG, et al. Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nature Communications. 11: 2895. PMID 32499578 DOI: 10.1038/S41467-020-16615-9 |
0.518 |
|
| 2020 |
Zhang D, Hu Q, Liu X, Ji Y, Chao HP, Liu Y, Tracz A, Kirk J, Buonamici S, Zhu P, Wang J, Liu S, Tang DG. Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer. Nature Communications. 11: 2089. PMID 32350277 DOI: 10.1038/S41467-020-15815-7 |
0.544 |
|
| 2020 |
Gopalakrishnan D, Kirk J, Davis J, George S, Levine EG, Beumer JH, Appleman LJ, Tang D, Chatta GS. A phase Ib trial of enzalutamide with venetoclax in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 38: TPS5599-TPS5599. DOI: 10.1200/jco.2020.38.15_suppl.tps5599 |
0.388 |
|
| 2019 |
Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter C, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, ... ... Tang DG, et al. LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nature Communications. 10: 5494. PMID 31792211 DOI: 10.1038/S41467-019-13532-4 |
0.544 |
|
| 2019 |
Wible DJ, Chao HP, Tang DG, Bratton SB. cancer mutations and alternative mRNA splicing reveal a conjugation switch that regulates ATG12-ATG5-ATG16L1 complex assembly and autophagy. Cell Discovery. 5: 42. PMID 31636955 DOI: 10.1038/S41421-019-0110-1 |
0.34 |
|
| 2019 |
Davis JE, Kirk J, Ji Y, Tang DG. Tumor Dormancy and Slow-Cycling Cancer Cells. Advances in Experimental Medicine and Biology. 1164: 199-206. PMID 31576550 DOI: 10.1007/978-3-030-22254-3_15 |
0.565 |
|
| 2019 |
Koutelou E, Wang L, Schibler A, Chao HP, Kuang X, Lin K, Lu Y, Shen J, Jeter CR, Salinger A, Wilson M, Chen YC, Atanassov BS, Tang DG, Dent SY. Usp22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta. Development (Cambridge, England). PMID 30718289 DOI: 10.1242/Dev.174037 |
0.396 |
|
| 2019 |
Xu B, Liu R, Chen M, Tang* DG. MP81-15 LNCRNA MEG3 FUNCTIONS AS A TUMOR-SUPPRESSOR IN PROSTATE CANCER Journal of Urology. 201. DOI: 10.1097/01.JU.0000557434.41195.1c |
0.473 |
|
| 2018 |
Zhang D, Zhao S, Li X, Kirk JS, Tang DG. Prostate Luminal Progenitor Cells in Development and Cancer. Trends in Cancer. 4: 769-783. PMID 30352679 DOI: 10.1016/J.Trecan.2018.09.003 |
0.622 |
|
| 2018 |
Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter C, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, ... ... Tang DG, et al. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nature Communications. 9: 3600. PMID 30190514 DOI: 10.1038/S41467-018-06067-7 |
0.489 |
|
| 2018 |
Zhang D, Tang DG. "Splice" a way towards neuroendocrine prostate cancer. Ebiomedicine. PMID 30177243 DOI: 10.1016/J.Ebiom.2018.08.037 |
0.514 |
|
| 2018 |
Choi TG, Nguyen MN, Kim J, Jo YH, Jang M, Nguyen NNY, Yun HR, Choe W, Kang I, Ha J, Tang DG, Kim SS. Cyclophilin B induces chemoresistance by degrading wild type p53 via interaction with MDM2 in colorectal cancer. The Journal of Pathology. PMID 29876924 DOI: 10.1002/Path.5107 |
0.355 |
|
| 2018 |
Skvortsov S, Skvortsova II, Tang DG, Dubrovska A. Prostate Cancer Stem Cells: Current Understanding. Stem Cells (Dayton, Ohio). PMID 29845679 DOI: 10.1002/Stem.2859 |
0.632 |
|
| 2018 |
Tomida J, Takata KI, Bhetawal S, Person MD, Chao HP, Tang DG, Wood RD. FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells. The Embo Journal. PMID 29789392 DOI: 10.15252/Embj.201899543 |
0.405 |
|
| 2018 |
Zhang D, Tang DG, Rycaj K. Cancer stem cells: regulation programs, immunological properties and immunotherapy. Seminars in Cancer Biology. PMID 29752993 DOI: 10.1016/J.Semcancer.2018.05.001 |
0.513 |
|
| 2017 |
Zhang D, Jeter C, Gong S, Tracz A, Lu Y, Shen J, Tang DG. Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration. Stem Cell Reports. PMID 29276153 DOI: 10.1016/J.Stemcr.2017.11.016 |
0.633 |
|
| 2017 |
Rycaj K, Tang DG. Molecular determinants of prostate cancer metastasis. Oncotarget. 8: 88211-88231. PMID 29152153 DOI: 10.18632/Oncotarget.21085 |
0.585 |
|
| 2017 |
Liu B, Gong S, Li Q, Chen X, Moore J, Suraneni MV, Badeaux MD, Jeter CR, Shen J, Mehmood R, Fan Q, Tang DG. Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model. Oncotarget. 8: 52746-52760. PMID 28881767 DOI: 10.18632/Oncotarget.17186 |
0.537 |
|
| 2017 |
Gao WQ, Guo Y, Zhang K, Cheng C, Ji Z, Wang X, Wang M, Chu M, Tang DG, Zhu HH. Numb(-/low) enriches a castration resistant prostate cancer cell subpopulation associated with enhanced Notch and Hedgehog signaling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28751447 DOI: 10.1158/1078-0432.Ccr-17-0913 |
0.618 |
|
| 2017 |
Liu B, Gong S, Li Q, Chen X, Moore J, Suraneni MV, Badeaux MD, Jeter CR, Shen J, Mehmood R, Fan Q, Tang DG. Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model. Oncotarget. PMID 28477021 DOI: 10.18632/oncotarget.17186 |
0.448 |
|
| 2017 |
Rycaj K, Li H, Zhou J, Chen X, Tang DG. Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Seminars in Cancer Biology. PMID 28408152 DOI: 10.1016/J.Semcancer.2017.03.009 |
0.57 |
|
| 2017 |
Zhang D, Lin K, Lu Y, Rycaj K, Zhong Y, Chao HP, Calhoun-Davis T, Shen J, Tang DG. Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer. Stem Cells Translational Medicine. 6: 748-760. PMID 28297567 DOI: 10.5966/Sctm.2016-0243 |
0.649 |
|
| 2017 |
Liu X, Krawczyk E, Suprynowicz FA, Palechor-Ceron N, Yuan H, Dakic A, Simic V, Zheng YL, Sripadhan P, Chen C, Lu J, Hou TW, Choudhury S, Kallakury B, Tang D, et al. Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens. Nature Protocols. 12: 439-451. PMID 28125105 DOI: 10.1038/Nprot.2016.174 |
0.494 |
|
| 2017 |
Liu C, Liu R, Zhang D, Deng Q, Liu B, Chao HP, Rycaj K, Takata Y, Lin K, Lu Y, Zhong Y, Krolewski J, Shen J, Tang DG. MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. Nature Communications. 8: 14270. PMID 28112170 DOI: 10.1038/Ncomms14270 |
0.447 |
|
| 2016 |
Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, Chen X, Li Q, Rycaj K, Calhoun-Davis T, Yan L, Hu Q, Wang J, Shen J, Liu S, ... Tang DG, et al. NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Discovery. 2: 16041. PMID 27867534 DOI: 10.1038/Celldisc.2016.41 |
0.593 |
|
| 2016 |
Zhang D, Lin K, Lu Y, Rycaj K, Zhong Y, Chao HP, Calhoun-Davis T, Shen J, Tang DG. Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer. Stem Cells Translational Medicine. PMID 27686757 DOI: 10.5966/sctm.2016-0243 |
0.58 |
|
| 2016 |
Liu R, Liu C, Zhang D, Liu B, Chen X, Rycaj K, Jeter C, Calhoun-Davis T, Li Y, Yang T, Wang J, Tang DG. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells. Oncotarget. PMID 27447749 DOI: 10.18632/Oncotarget.10652 |
0.503 |
|
| 2016 |
Ellis L, Ku S, Li Q, Azabdaftari G, Seliski J, Olson B, Netherby CS, Tang DG, Abrams SI, Goodrich DW, Pili R. Generation of a C57BL/6 MYC-driven mouse model and cell line of prostate cancer. The Prostate. PMID 27225803 DOI: 10.1002/Pros.23206 |
0.565 |
|
| 2016 |
Atanassov BS, Mohan RD, Lan X, Kuang X, Lu Y, Lin K, McIvor E, Li W, Zhang Y, Florens L, Byrum SD, Mackintosh SG, Calhoun-Davis T, Koutelou E, Wang L, ... Tang DG, et al. ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth. Molecular Cell. PMID 27132940 DOI: 10.1016/J.Molcel.2016.03.030 |
0.435 |
|
| 2016 |
Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter C, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG. Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer (CRPC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27060154 DOI: 10.1158/1078-0432.Ccr-15-2956 |
0.616 |
|
| 2016 |
Zhang D, Park D, Zhong Y, Lu Y, Rycaj K, Gong S, Chen X, Liu X, Chao HP, Whitney P, Calhoun-Davis T, Takata Y, Shen J, Iyer VR, Tang DG. Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer. Nature Communications. 7: 10798. PMID 26924072 DOI: 10.1038/Ncomms10798 |
0.603 |
|
| 2016 |
Rycaj K, Cho EJ, Liu X, Chao HP, Liu B, Li Q, Devkota AK, Zhang D, Chen X, Moore J, Dalby KN, Tang DG. Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cells. Oncotarget. PMID 26871947 DOI: 10.18632/Oncotarget.7303 |
0.574 |
|
| 2016 |
Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Liu H, Rodriguez-Canales J, Sphyris N, Wistuba I, Miura N, Dhillon J, Mahajan N, Mahajan K, Chang JT, Ittmann M, ... ... Tang DG, et al. Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties. Oncogene. PMID 26804168 DOI: 10.1038/Onc.2015.498 |
0.666 |
|
| 2016 |
Zhang D, Park D, Lu Y, Shen J, Iyer VR, Tang DG. Deep RNA-Seq analysis reveals unexpected features of human prostate basal epithelial cells Genomics Data. 7: 318-320. DOI: 10.1016/J.Gdata.2015.09.003 |
0.585 |
|
| 2015 |
Tang DG. Cancers of the breast and prostate: a stem cell perspective. Endocrine-Related Cancer. 22: E9-E11. PMID 26487552 DOI: 10.1530/Erc-15-0427 |
0.599 |
|
| 2015 |
Rycaj K, Tang DG. Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations. Cancer Research. 75: 4003-11. PMID 26292361 DOI: 10.1158/0008-5472.Can-15-0798 |
0.597 |
|
| 2015 |
Deng Q, Tang DG. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications. Endocrine-Related Cancer. 22: T209-20. PMID 26285606 DOI: 10.1530/Erc-15-0217 |
0.612 |
|
| 2015 |
Liu X, Chen X, Rycaj K, Chao HP, Deng Q, Jeter C, Liu C, Honorio S, Li H, Davis T, Suraneni M, Laffin B, Qin J, Li Q, Yang T, ... ... Tang DG, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. PMID 26246472 DOI: 10.18632/Oncotarget.4260 |
0.684 |
|
| 2015 |
Li Q, Rycaj K, Chen X, Tang DG. Cancer stem cells and cell size: A causal link? Seminars in Cancer Biology. PMID 26241348 DOI: 10.1016/J.Semcancer.2015.07.002 |
0.522 |
|
| 2015 |
Gong S, Li Q, Jeter CR, Fan Q, Tang DG, Liu B. Regulation of NANOG in cancer cells. Molecular Carcinogenesis. PMID 26013997 DOI: 10.1002/Mc.22340 |
0.566 |
|
| 2015 |
Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM. Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Reports in Oncological Medicine. 2015: 471861. PMID 25861496 DOI: 10.1155/2015/471861 |
0.519 |
|
| 2015 |
Jeter CR, Yang T, Wang J, Chao HP, Tang DG. Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells (Dayton, Ohio). PMID 25821200 DOI: 10.1002/Stem.2007 |
0.513 |
|
| 2015 |
Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG, Wang-Johanning F. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 471-83. PMID 25370465 DOI: 10.1158/1078-0432.Ccr-14-0388 |
0.501 |
|
| 2015 |
Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Bhangre N, Liu H, Rodriguez-Canales J, Wistuba II, Chang JT, Tang DG, Mahajan N, Mahajan K, Miura N, Mani SA. Abstract 4065: Delineating the role of epithelial-mesenchymal transition in the generation and maintenance of prostate cancer stem cells Cancer Research. 75: 4065-4065. DOI: 10.1158/1538-7445.Am2015-4065 |
0.636 |
|
| 2014 |
Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter C, Chen X, Vlassov AV, Tang DG. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Research. 74: 4183-95. PMID 24903149 DOI: 10.1158/0008-5472.Can-14-0404 |
0.522 |
|
| 2014 |
Suraneni MV, Moore JR, Zhang D, Badeaux M, Macaluso MD, DiGiovanni J, Kusewitt D, Tang DG. Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer. Cell Cycle (Georgetown, Tex.). 13: 1798-810. PMID 24732589 DOI: 10.4161/Cc.28757 |
0.603 |
|
| 2014 |
Yang T, Rycaj K, Liu ZM, Tang DG. Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets. Cancer Research. 74: 2922-7. PMID 24713433 DOI: 10.1158/0008-5472.Can-14-0266 |
0.525 |
|
| 2014 |
Liu B, Badeaux MD, Choy G, Chandra D, Shen I, Jeter CR, Rycaj K, Lee CF, Person MD, Liu C, Chen Y, Shen J, Jung SY, Qin J, Tang DG. Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species. Plos One. 9: e90615. PMID 24598770 DOI: 10.1371/Journal.Pone.0090615 |
0.445 |
|
| 2014 |
Shi Y, Liu C, Liu X, Tang DG, Wang J. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. Plos One. 9: e90022. PMID 24595209 DOI: 10.1371/Journal.Pone.0090022 |
0.382 |
|
| 2014 |
Rycaj K, Tang DG. Cancer stem cells and radioresistance. International Journal of Radiation Biology. 90: 615-21. PMID 24527669 DOI: 10.3109/09553002.2014.892227 |
0.444 |
|
| 2014 |
Suraneni MV, Moore JR, Zhang D, Badeaux M, Macaluso MD, DiGiovanni J, Kusewitt D, Tang DG. Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer Cell Cycle. 13: 1-13. DOI: 10.4161/cc.28757 |
0.48 |
|
| 2013 |
Badeaux MA, Jeter CR, Gong S, Liu B, Suraneni MV, Rundhaug J, Fischer SM, Yang T, Kusewitt D, Tang DG. In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle (Georgetown, Tex.). 12: 2395-408. PMID 23839044 DOI: 10.4161/Cc.25402 |
0.477 |
|
| 2013 |
Chen X, Liu B, Li Q, Honorio S, Liu X, Liu C, Multani AS, Calhoun-Davis T, Tang DG. Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice. Plos One. 8: e56903. PMID 23451107 DOI: 10.1371/Journal.Pone.0056903 |
0.586 |
|
| 2013 |
Du L, Rao G, Wang H, Li B, Tian W, Cui J, He L, Laffin B, Tian X, Hao C, Liu H, Sun X, Zhu Y, Tang DG, Mehrpour M, et al. CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer. Cancer Research. 73: 2682-94. PMID 23418321 DOI: 10.1158/0008-5472.Can-12-3759 |
0.525 |
|
| 2013 |
Chen X, Rycaj K, Liu X, Tang DG. New insights into prostate cancer stem cells. Cell Cycle (Georgetown, Tex.). 12: 579-86. PMID 23370446 DOI: 10.4161/Cc.23721 |
0.626 |
|
| 2013 |
Zhang L, Xiao R, Xiong J, Leng J, Ehtisham A, Hu Y, Ding Q, Xu H, Liu S, Wang J, Tang DG, Zhang Q. Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25. Plos One. 8: e52384. PMID 23326330 DOI: 10.1371/Journal.Pone.0052384 |
0.319 |
|
| 2013 |
Gogada R, Yadav N, Liu J, Tang S, Zhang D, Schneider A, Seshadri A, Sun L, Aldaz CM, Tang DG, Chandra D. Bim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer. The Journal of Biological Chemistry. 288: 368-81. PMID 23152504 DOI: 10.1074/Jbc.M112.386102 |
0.567 |
|
| 2012 |
Liu C, Kelnar K, Vlassov AV, Brown D, Wang J, Tang DG. Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Research. 72: 3393-404. PMID 22719071 DOI: 10.1158/0008-5472.Can-11-3864 |
0.557 |
|
| 2012 |
Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, ... Tang DG, et al. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell. 10: 556-69. PMID 22560078 DOI: 10.1016/J.Stem.2012.03.009 |
0.676 |
|
| 2012 |
Tang DG. Understanding cancer stem cell heterogeneity and plasticity Cell Research. 22: 457-472. PMID 22357481 DOI: 10.1038/Cr.2012.13 |
0.55 |
|
| 2012 |
Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, ... Tang DG, et al. Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations. Pathology Oncology Research : Por. 2: 98-109. PMID 18443924 DOI: 10.1007/Bf02893960 |
0.476 |
|
| 2012 |
Jeter CR, Lu Y, Liu B, Gaddis S, Liang S, Tang DG. Abstract B22: Molecular oncogenesis of NANOG in castration-resistant prostate cancer Cancer Prevention Research. 5: B22-B22. DOI: 10.1158/1940-6207.Prev-12-B22 |
0.638 |
|
| 2012 |
Liu X, Chen X, Laffin B, Yin B, Calhoun-Davis T, Wang-Johanning F, Tang DG. Abstract C68: Phenotypic and functional heterogeneity of prostate cancer stem cells Cancer Research. 72: C68-C68. DOI: 10.1158/1538-7445.Prca2012-C68 |
0.671 |
|
| 2012 |
Chen X, Fokt I, Skora S, Priebe W, Bi Y, Tang DG, Yan H, Zhang Q, Qin J, Li H, Liu C, Davis T, Coletta LD, Klostergaard J. Abstract C65: Drug-tolerant cancer cells show reduced tumor-initiating capacity: Depletion of CD44+ cells and evidence for epigenetic mechanisms Cancer Research. 72: C65-C65. DOI: 10.1158/1538-7445.Prca2012-C65 |
0.556 |
|
| 2012 |
Jeter CR, Tang DG. Prostate Tissue Stem Cells and Prostate Cancer Progression Reviews in Cell Biology and Molecular Medicine. DOI: 10.1002/3527600906.Mcb.201200008 |
0.656 |
|
| 2011 |
Yan H, Chen X, Zhang Q, Qin J, Li H, Liu C, Calhoun-Davis T, Coletta LD, Klostergaard J, Fokt I, Skora S, Priebe W, Bi Y, Tang DG. Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms. Plos One. 6: e24397. PMID 21935404 DOI: 10.1371/Journal.Pone.0024397 |
0.536 |
|
| 2011 |
Liu C, Tang DG. MicroRNA regulation of cancer stem cells. Cancer Research. 71: 5950-4. PMID 21917736 DOI: 10.1158/0008-5472.Can-11-1035 |
0.479 |
|
| 2011 |
Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, Repass J, Zaehres H, Shen JJ, Tang DG. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 30: 3833-45. PMID 21499299 DOI: 10.1038/Onc.2011.114 |
0.654 |
|
| 2011 |
Li H, Tang DG. Prostate cancer stem cells and their potential roles in metastasis. Journal of Surgical Oncology. 103: 558-62. PMID 21480250 DOI: 10.1002/jso.21806 |
0.573 |
|
| 2011 |
Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine. 17: 211-5. PMID 21240262 DOI: 10.1038/Nm.2284 |
0.831 |
|
| 2011 |
Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter C, Calhoun-Davis T, Li H, Ivanov I, Palapattu G, Pang S, Huang J, Suraneni M, Tang DG. Abstract 476: Defining two populations of prostate cancer cells with distinct molecular, biological, and tumor-propagating properties Cancer Research. 71: 476-476. DOI: 10.1158/1538-7445.Am2011-476 |
0.656 |
|
| 2010 |
Laffin B, Tang DG. An old player on a new playground: bmi-1 as a regulator of prostate stem cells. Cell Stem Cell. 7: 639-40. PMID 21112554 DOI: 10.1016/J.Stem.2010.11.019 |
0.587 |
|
| 2010 |
Suraneni MV, Schneider-Broussard R, Moore JR, Davis TC, Maldonado CJ, Li H, Newman RA, Kusewitt D, Hu J, Yang P, Tang DG. Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence. Oncogene. 29: 4261-75. PMID 20514017 DOI: 10.1038/Onc.2010.197 |
0.563 |
|
| 2010 |
Jiang M, Strand DW, Fernandez S, He Y, Yi Y, Birbach A, Qiu Q, Schmid J, Tang DG, Hayward SW. Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells (Dayton, Ohio). 28: 344-56. PMID 20020426 DOI: 10.1002/Stem.284 |
0.609 |
|
| 2009 |
Chandra D, Tang DG. Detection of apoptosis in cell-free systems. Methods in Molecular Biology (Clifton, N.J.). 559: 65-75. PMID 19609749 DOI: 10.1007/978-1-60327-017-5_5 |
0.327 |
|
| 2009 |
Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG. Methodologies in assaying prostate cancer stem cells. Methods in Molecular Biology (Clifton, N.J.). 568: 85-138. PMID 19582423 DOI: 10.1007/978-1-59745-280-9_7 |
0.841 |
|
| 2009 |
Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (Dayton, Ohio). 27: 993-1005. PMID 19415763 DOI: 10.1002/Stem.29 |
0.856 |
|
| 2009 |
Chen X, Schneider-Broussard R, Hollowell D, McArthur M, Jeter CR, Benavides F, DiGiovanni J, Tang DG. Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice. Differentiation; Research in Biological Diversity. 77: 324-34. PMID 19272531 DOI: 10.1016/J.Diff.2008.10.011 |
0.333 |
|
| 2009 |
Jeter CR, Tang DG. Prostate cancer stem cells Cancer Stem Cells. 15-30. DOI: 10.1017/CBO9780511605536.003 |
0.466 |
|
| 2008 |
Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, Schneider-Broussard R, Multani AS, Jeter CR, Calhoun-Davis T, Hu L, Hu J, Tsavachidis S, Zhang W, Chang S, Hayward SW, ... Tang DG, et al. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. The Journal of Biological Chemistry. 283: 27957-72. PMID 18662989 DOI: 10.1074/Jbc.M803467200 |
0.815 |
|
| 2008 |
Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Research. 68: 1820-5. PMID 18339862 DOI: 10.1158/0008-5472.Can-07-5878 |
0.637 |
|
| 2008 |
Bhatia B, Multani AS, Patrawala L, Chen X, Calhoun-Davis T, Zhou J, Schroeder L, Schneider-Broussard R, Shen J, Pathak S, Chang S, Tang DG. Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. International Journal of Cancer. Journal International Du Cancer. 122: 1483-95. PMID 18059027 DOI: 10.1002/Ijc.23222 |
0.834 |
|
| 2007 |
Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Research. 67: 6796-805. PMID 17638891 DOI: 10.1158/0008-5472.Can-07-0490 |
0.855 |
|
| 2007 |
Tang DG, Bhatia B, Tang S, Schneider-Broussard R. 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins & Other Lipid Mediators. 82: 135-46. PMID 17164141 DOI: 10.1016/J.Prostaglandins.2006.05.022 |
0.854 |
|
| 2007 |
Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Molecular Carcinogenesis. 46: 1-14. PMID 16921491 DOI: 10.1002/Mc.20255 |
0.837 |
|
| 2007 |
Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Erratum: Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44+α2β1+ cell population is enriched in tumor-initiating cells (Cancer Research (2007) 67, (6796-6805)) Cancer Research. 67. DOI: 10.1158/0008-5472.Can-67-18-Cor1 |
0.856 |
|
| 2006 |
Chandra D, Bratton SB, Person MD, Tian Y, Martin AG, Ayres M, Fearnhead HO, Gandhi V, Tang DG. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome. Cell. 125: 1333-46. PMID 16814719 DOI: 10.1016/J.Cell.2006.05.026 |
0.363 |
|
| 2006 |
Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 25: 1696-708. PMID 16449977 DOI: 10.1038/Sj.Onc.1209327 |
0.809 |
|
| 2005 |
Choy G, Liu JW, Chandra D, Tang DG. Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. ProgrèS Des Recherches Pharmaceutiques. 63: 115-45. PMID 16265879 DOI: 10.1007/3-7643-7414-4_6 |
0.374 |
|
| 2005 |
Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Research. 65: 6207-19. PMID 16024622 DOI: 10.1158/0008-5472.Can-05-0592 |
0.84 |
|
| 2005 |
Chandra D, Choy G, Daniel PT, Tang DG. Bax-dependent regulation of Bak by voltage-dependent anion channel 2. The Journal of Biological Chemistry. 280: 19051-61. PMID 15757910 DOI: 10.1074/Jbc.M501391200 |
0.447 |
|
| 2005 |
Bhatia B, Tang S, Yang P, Doll A, Aumüeller G, Newman RA, Tang DG. Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells. Oncogene. 24: 3583-95. PMID 15750631 DOI: 10.1038/Sj.Onc.1208406 |
0.859 |
|
| 2005 |
Liu JW, Chandra D, Rudd MD, Butler AP, Pallotta V, Brown D, Coffer PJ, Tang DG. Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene. 24: 2020-31. PMID 15674333 DOI: 10.1038/Sj.Onc.1208385 |
0.334 |
|
| 2004 |
Chandra D, Choy G, Deng X, Bhatia B, Daniel P, Tang DG. Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. Molecular and Cellular Biology. 24: 6592-607. PMID 15254227 DOI: 10.1128/Mcb.24.15.6592-6607.2004 |
0.729 |
|
| 2004 |
Tang S, Bhatia B, Zhou J, Maldonado CJ, Chandra D, Kim E, Fischer SM, Butler AP, Friedman SL, Tang DG. Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells. Oncogene. 23: 6942-53. PMID 15247906 DOI: 10.1038/Sj.Onc.1207913 |
0.796 |
|
| 2003 |
Bhatia B, Maldonado CJ, Tang S, Chandra D, Klein RD, Chopra D, Shappell SB, Yang P, Newman RA, Tang DG. Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. The Journal of Biological Chemistry. 278: 25091-100. PMID 12704195 DOI: 10.1074/Jbc.M301920200 |
0.817 |
|
| 2003 |
Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia (New York, N.Y.). 5: 121-7. PMID 12659684 DOI: 10.1016/S1476-5586(03)80003-9 |
0.42 |
|
| 2003 |
Liu JW, Shen JJ, Tanzillo-Swarts A, Bhatia B, Maldonado CM, Person MD, Lau SS, Tang DG. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene. 22: 1475-85. PMID 12629510 DOI: 10.1038/Sj.Onc.1206196 |
0.837 |
|
| 2002 |
Tang DG, La E, Kern J, Kehrer JP. Fatty acid oxidation and signaling in apoptosis. Biological Chemistry. 383: 425-42. PMID 12033433 DOI: 10.1515/Bc.2002.046 |
0.387 |
|
| 2002 |
Liu JW, Chandra D, Tang SH, Chopra D, Tang DG. Identification and characterization of Bimgamma, a novel proapoptotic BH3-only splice variant of Bim. Cancer Research. 62: 2976-81. PMID 12019181 |
0.48 |
|
| 2002 |
Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J, Chandra D, Traag J, Klein RD, Fischer SM, Chopra D, Shen J, Zhau HE, Chung LW, Tang DG. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. The Journal of Biological Chemistry. 277: 16189-201. PMID 11839751 DOI: 10.1074/Jbc.M111936200 |
0.84 |
|
| 2001 |
Tokumoto YM, Tang DG, Raff MC. Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. The Embo Journal. 20: 5261-8. PMID 11566889 DOI: 10.1093/Emboj/20.18.5261 |
0.351 |
|
| 2001 |
Raff M, Apperly J, Kondo T, Tokumoto Y, Tang D. Timing cell-cycle exit and differentiation in oligodendrocyte development Novartis Foundation Symposium. 237: 100-112. PMID 11444039 DOI: 10.1002/0470846666.CH9 |
0.35 |
|
| 2001 |
Tang DG, Tokumoto YM, Apperly JA, Lloyd AC, Raff MC. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science (New York, N.Y.). 291: 868-71. PMID 11157165 DOI: 10.1126/Science.1056780 |
0.462 |
|
| 2000 |
Tang DG, Tokumoto YM, Raff MC. Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. The Journal of Cell Biology. 148: 971-84. PMID 10704447 DOI: 10.1083/Jcb.148.5.971 |
0.333 |
|
| 1999 |
Ben-Josef E, Yang SY, Ji TH, Bidart JM, Garde SV, Chopra DP, Porter AT, Tang DG. Hormone-refractory prostate cancer cells express functional follicle- stimulating hormone receptor (FSHR) Journal of Urology. 161: 970-976. PMID 10022736 DOI: 10.1016/S0022-5347(01)61831-7 |
0.584 |
|
| 1999 |
Garde SV, Basrur VS, Li L, Finkelman MA, Krishan A, Wellham L, Ben-Josef E, Haddad M, Taylor JD, Porter AT, Tang DG. Prostate secretory protein (PSP94) suppresses the growth of androgen- independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis Prostate. 38: 118-125. PMID 9973097 DOI: 10.1002/(Sici)1097-0045(19990201)38:2<118::Aid-Pros5>3.0.Co;2-G |
0.561 |
|
| 1999 |
Tang DG, Li L, Zhu Z, Joshi B, Johnson CR, Marnett LJ, Honn KV, Crissman JD, Krajewski S, Reed JC, Timar J, Porter AT. BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases. Pathology Oncology Research : Por. 4: 179-90. PMID 9761936 DOI: 10.1007/Bf02905247 |
0.489 |
|
| 1998 |
Rice RL, Tang DG, Taylor JD. Actin cleavage in various tumor cells is not a critical requirement for executing apoptosis. Pathology Oncology Research : Por. 4: 135-45. PMID 9654600 DOI: 10.1007/Bf02904708 |
0.392 |
|
| 1998 |
Rice RL, Tang DG, Haddad M, Honn KV, Taylor JD. 12(S)-hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: a protein kinase-dependent process. International Journal of Cancer. Journal International Du Cancer. 77: 271-8. PMID 9650564 DOI: 10.1002/(Sici)1097-0215(19980717)77:2<271::Aid-Ijc17>3.0.Co;2-E |
0.301 |
|
| 1998 |
Tang DG, Honn KV. Role of protein kinase C and phosphatases in 12(S)-HETE-induced tumor cell cytoskeletal reorganization. Advances in Experimental Medicine and Biology. 349-61. PMID 9547577 DOI: 10.1007/978-1-4615-5325-0_48 |
0.348 |
|
| 1998 |
Tang DG, Li L, Zhu Z, Joshi B. Apoptosis in the absence of cytochrome c accumulation in the cytosol. Biochemical and Biophysical Research Communications. 242: 380-4. PMID 9446803 DOI: 10.1006/Bbrc.1997.7969 |
0.333 |
|
| 1997 |
Tang DG, Guan KL, Li L, Honn KV, Chen YQ, Rice RL, Taylor JD, Porter AT. Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. International Journal of Cancer. Journal International Du Cancer. 72: 1078-87. PMID 9378543 DOI: 10.1002/(Sici)1097-0215(19970917)72:6<1078::Aid-Ijc24>3.0.Co;2-# |
0.399 |
|
| 1997 |
Tang DG, Porter AT, Honn KV. Critical role of arachidonate lipoxygenases in regulating apoptosis. Advances in Experimental Medicine and Biology. 407: 405-11. PMID 9321984 DOI: 10.1007/978-1-4899-1813-0_61 |
0.431 |
|
| 1997 |
Tang DG, Porter AT. Target to apoptosis: a hopeful weapon for prostate cancer. The Prostate. 32: 284-93. PMID 9288188 DOI: 10.1002/(Sici)1097-0045(19970901)32:4<284::Aid-Pros9>3.0.Co;2-J |
0.522 |
|
| 1997 |
Tang DG, Honn KV. Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival. Journal of Cellular Physiology. 172: 155-70. PMID 9258337 DOI: 10.1002/(Sici)1097-4652(199708)172:2<155::Aid-Jcp3>3.0.Co;2-N |
0.485 |
|
| 1996 |
Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell, Redman B, Sakr W, Severson R, ... Tang DG, et al. Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment. Pathology Oncology Research : Por. 2: 276-292. PMID 11173616 DOI: 10.1007/Bf02904824 |
0.487 |
|
| 1996 |
Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes EJ, Powell, Redman B, Sakr W, Severson R, ... Tang DG, et al. Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects). Pathology Oncology Research : Por. 2: 191-211. PMID 11173606 DOI: 10.1007/Bf02903527 |
0.566 |
|
| 1996 |
Tang DG, Porter AT. Apoptosis: A Current Molecular Analysis. Pathology Oncology Research : Por. 2: 117-131. PMID 11173595 DOI: 10.1007/Bf02903515 |
0.433 |
|
| 1996 |
Tang DG, Diglio CA, Honn KV. Tyrosine Phosphorylation of a ~30 kD Protein Precedes avb3 Integrin-signaled Endothelial Cell Spreading and Motility on Matrix Proteins. Pathology Oncology Research : Por. 2: 21-29. PMID 11173578 DOI: 10.1007/Bf02893943 |
0.39 |
|
| 1996 |
Tang DG, Chen YQ, Honn KV. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 93: 5241-6. PMID 8643560 DOI: 10.1073/Pnas.93.11.5241 |
0.43 |
|
| 1995 |
Tang DG, Tarrien M, Dobrzynski P, Honn KV. Melanoma cell spreading on fibronectin induced by 12(S)-HETE involves both protein kinase C- and protein tyrosine kinase-dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK). Journal of Cellular Physiology. 165: 291-306. PMID 7593207 DOI: 10.1002/Jcp.1041650210 |
0.343 |
|
| 1995 |
Tang DG, Renaud C, Stojakovic S, Diglio CA, Porter A, Honn KV. 12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochemical and Biophysical Research Communications. 211: 462-8. PMID 7540838 DOI: 10.1006/Bbrc.1995.1836 |
0.372 |
|
| 1995 |
Tang DG, Grossi IM, Tang KQ, Diglio CA, Honn KV. Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects. International Journal of Cancer. 60: 418-25. PMID 7530235 DOI: 10.1002/Ijc.2910600325 |
0.404 |
|
| 1994 |
Honn KV, Tang DG, Grossi IM, Renaud C, Duniec ZM, Johnson CR, Diglio CA. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Experimental Cell Research. 210: 1-9. PMID 8269984 DOI: 10.1006/Excr.1994.1001 |
0.511 |
|
| 1994 |
Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J, Hagmann W. 12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis Cancer and Metastasis Reviews. 13: 365-396. PMID 7712597 DOI: 10.1007/Bf00666105 |
0.516 |
|
| 1994 |
Schneider MR, Tang DG, Schirner M, Honn KV. Prostacyclin and its analogues: antimetastatic effects and mechanisms of action Cancer and Metastasis Reviews. 13: 349-364. PMID 7712596 DOI: 10.1007/Bf00666104 |
0.484 |
|
| 1993 |
Timar J, Tang D, Bazaz R, Haddad MM, Kimler VA, Taylor JD, Honn KV. PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells. Cell Motility and the Cytoskeleton. 26: 49-65. PMID 8221907 DOI: 10.1002/Cm.970260106 |
0.427 |
|
| 1993 |
Tang DG, Timar J, Grossi IM, Renaud C, Kimler VA, Diglio CA, Taylor JD, Honn KV. The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Experimental Cell Research. 207: 361-75. PMID 7688315 DOI: 10.1006/Excr.1993.1203 |
0.347 |
|
| 1993 |
Wojtukiewicz MZ, Tang DG, Ciarelli JJ, Nelson KK, Walz DA, Diglio CA, Mammen EF, Honn KV. Thrombin increases the metastatic potential of tumor cells International Journal of Cancer. 54: 793-806. PMID 7686887 DOI: 10.1002/Ijc.2910540514 |
0.488 |
|
| 1993 |
Tang DG, Chen YQ, Diglio CA, Honn KV. Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor. The Journal of Cell Biology. 121: 689-704. PMID 7683691 DOI: 10.1083/Jcb.121.3.689 |
0.319 |
|
| 1993 |
Tang DG, Onoda JM, Steinert BW, Grossi IM, Nelson KK, Umbarger L, Diglio CA, Taylor JD, Honn KV. Phenotypic properties of cultured tumor cells: Integrin α(IIb)β3 expression, tumor-cell-induced platelet aggregation, and tumor-cell adhesion to endothelium as important parameters of experimental metastasis International Journal of Cancer. 54: 338-347. PMID 7683632 DOI: 10.1002/Ijc.2910540229 |
0.48 |
|
| 1993 |
Honn KV, Tang DG, Chen YQ. Platelets and cancer metastasis: more than an epiphenomenon. Seminars in Thrombosis and Hemostasis. 18: 392-415. PMID 1470927 DOI: 10.1055/S-2007-1002578 |
0.455 |
|
| 1992 |
Chen YQ, Liu B, Tang DG, Honn KV. Fatty acid modulation of tumor cell-platelet-vessel wall interaction. Cancer Metastasis Reviews. 11: 389-409. PMID 1423824 DOI: 10.1007/Bf01307189 |
0.46 |
|
| 1992 |
Honn KV, Tang DG. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Reviews. 11: 353-75. PMID 1423822 DOI: 10.1007/Bf01307187 |
0.448 |
|
| 1992 |
Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: A causal relationship? Cancer and Metastasis Reviews. 11: 325-351. PMID 1423821 DOI: 10.1007/Bf01307186 |
0.507 |
|
| 1992 |
Wojtukicwicz MZ, Tang DG, Nelson KK, Walz DA, Diglio CA, Honn KV. Thrombin enhances tumor cell adhesive and metastatic properties via increased αIIbβ3 expression on the cell surface Thrombosis Research. 68: 233-245. PMID 1281930 DOI: 10.1016/0049-3848(92)90081-K |
0.522 |
|
| Show low-probability matches. |